Renal Dialysis and its Financing.
The incidence of end-stage renal disease (ESRD) and its associated comorbidities such as diabetes and hypertension continue to increase as the population ages. As most ESRD patients qualify for Medicare coverage, the U.S. government initiated reforms of the payment system for dialysis facilities in an effort to decrease expenditures associated with ESRD reimbursement. The effects of reduced reimbursement rates, bundled payment options, and quality incentives on the current dialysis system, including kidney dialysis units, physicians, and patients, are examined.
a Marjorie K. Unterberg School of Nursing and Health Studies , Monmouth University , West Long Branch, New Jersey , USA.
Marisa
M
Borelli
b Leon Hess Business School , Monmouth University , West Long Branch, New Jersey , USA.
David P
DP
Paul
b Leon Hess Business School , Monmouth University , West Long Branch, New Jersey , USA.
Michaeline
M
Skiba
D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D006278:Medicare / Q000191:economics; D012051:Reimbursement Mechanisms; D006435:Renal Dialysis / Q000191:economics*; D014481:United States
End-stage renal disease (ESRD); Medicare; dialysis; payment reform